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: Fair Labor Standards and the Pharmaceuticals Industry

THE FAIR LABOR STANDARDS ACT EXEMPTIONS AND THE
PHARMACEUTICALS INDUSTRY: ARE SALES REPRESENTATIVES
ENTITLED TO OVERTIME?
Steven I. Locke1
INTRODUCTION
The pharmaceuticals industry is enormous. More than three billion prescriptions are written each year for approximately 8,000 products. 2 According to 2004
statistics, these prescriptions were filled by 54,000 retail pharmacies, and sales
totaled $168 billion. 3 Some more recent estimates put global sales totals in excess
of $820 billion. 4 Although drug companies engage in direct advertising, the bulk
of promotions are aimed directly at doctors and other medical prescribers. 5 Reported amounts on this type of promotional spending vary, with the yearly range
being between four and fourteen billion dollars.6 This type of activity is done
through face-to-face advocacy by sales representatives who visit doctors’ offices
and hospitals in order to meet with prescribing health care professionals. 7 The average primary care physician interacts with no less than twenty-eight sales representatives each week, and the average specialist interacts with fourteen. 8
According to the Bureau of Labor Statistics, in 2006, the pharmaceutical industry employed 292,000 workers across the country. 9 Of this number, it has been
________________________

1.
Steven I. Locke is a founding partner of Carabba Locke LLP and practices extensively in the areas of
labor and employment law.
2.
Trends and Indicators in the Changing Health Care Marketplace, Kaiser Family Foundation [hereinafter
Trends and Indicators], available at http://www.kff.org/insurance/7031/print-sec1.cfm (cited in IMS Health Inc. v.
Ayotte, 550 F.3d 42, 70 (1st Cir. 2008) (Lipez, J., concurring in part and dissenting in part)).
3.
Id.
4.
Press Release, NAPRx Forecasts 4.5 – 5.5 Percent Growth for Pharmaceutical Market in 2009, Exceeding $820 Billion (Jan. 7, 2009), available at http://www.prlog.org/10164237-naprx-forecasts-45-55-percentgrowth-for-pharmaceutucals.
5.
IMS Health, 550 F.3d at 46.
6.
Id.
7.
See, e.g., IMS Health, 550 F.3d at 70 n.17 (concurring and dissenting opinion) (collecting references
Susan Okie, AMA Criticized for Letting Drug Firms Pay for Ethics Campaign, WASH. POST, Aug. 30, 2001 at A3
(the industry spent about $4 billion in 2000); Memorandum from Rep. Harry Waxman, to the Democratic Members of the Committee on Government Reform, The Marketing of Vioxx to Physicians, at 6 n.15 (May 5, 2005)
(the $5.7 billion in 2003); Trends and Indicators, supra note 2, at 22 ($7.8 billion in 2004); Sheryl Gay Stolberg &
Jeff Gerth, High-Tech Stealth Being Used to Sway Doctors Prescriptions, N.Y. TIMES, Nov. 16, 2000 at A1 ($13.9
billion in 1999).
8.
Id.
at
47;
Consumers
Union,
Prescription
for
Change,
http://www.consumersunion.org/pdf/drugreps.pdf.
9.
Bureau of Labor Statistics, Career Guide to Industries, Pharmaceutical and Medicine Manufacturing,
Table 1, Employment of wage and salary workers in pharmaceutical and medicine manufacturing by occupation,
2006 and projected change, 2006-2016 (Dec. 18, 2007), http://www.bls.gov/oco/cg/CGS009.htm (accessed Apr.
29, 2009).
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estimated that as many as 100,000 serve as sales representatives. 10 Employers prefer to give these sales representative positions and other related jobs to college graduates, particularly those with science backgrounds, and most new sales representatives must complete “rigorous formal training programs” involving their employer’s products.11 Recent yearly salary estimates for sales representatives vary
with some surveys indicating a range between $85,000 and $110,000. 12 Overall
compensation, however, can increase dramatically depending on whether sales
quotas for the sales representatives are met or exceeded.13
Presently, and as explained in detail below, a battle is raging in the courts as to
whether these highly compensated sales representatives are entitled to overtime pay
under the Fair Labor Standards Act (“FLSA” or the “Act”), or whether they are
excluded from such an entitlement under one or more of the Act’s “exemptions.”
As these cases are winding their way through the United States District Courts and
appeals are starting to be taken, this article conducts a review of the courts’ various
conflicting positions and charts a course for addressing the issue before the Courts
of Appeals and ultimately the Supreme Court.
THE FAIR LABOR STANDARDS ACT
The Fair Labor Standards Act was enacted by Congress in 1938 14 to correct
and eliminate labor conditions “detrimental to the maintenance of the minimum
standard of living necessary for health, efficiency, and general well-being of workers.”15 The cornerstone of the Act was to provide minimum wages and overtime
pay for covered workers.16 According to these requirements, covered employees
________________________

10.
See, e.g., Linda Wang, Prescription for Success in Sales, EMP. OUTLOOK, Vol. 85, No. 8 at 43-46 (Feb.
19, 2007), available at http://pubs.acs.org/cen/employment/85/8508employment.html (“In the past 10 [sic] years,
the number of pharmaceutical sales representatives in the U.S. has tripled from 35,000 in 1995 to 100,000 today,
says Bob Davenport, vice president and managing director for the consulting firm Hay Group”). See also John
Mack, Fewer Sales Reps Lead to Higher Costs, Nov. 10, 2008, http://pharmamkting.blogspot.com/2008/11/lesssales-reps-lead-to-higher-costs.html citing Anthony Vecchione, Sales Force Report: Loop of Faith, MED.
MARKETING & MEDIA, Nov. 2008, at 38, available at http:/www.mmm-online.com/Sales-Force-Report-Loop-ofFaith/article/120164/ (sales force numbers have been declining since 2005 when they peaked at 99,910 to 97,963
in 2006 and 94,308 in 2007. The number further declined in 2008 to 91,652). Accord In re Novartis Wage &
Hour Litig., 593 F. Supp. 2d 637, 641 (S.D.N.Y. 2009) (stating that of 13,000 employees nationwide, 6000 were
sales representatives); Amendola v. Bristol-Myers Squibb Co., 558 F. Supp.2d 459, 463 (S.D.N.Y. 2008) (company employs “about 2400” pharmaceutical representatives); Wang, supra note 10 (GlaxoSmithKline had approximately 10,000 sales representatives in 2007).
11.
Trends and Indicators, supra note 2.
12.
Pharmaceutical Sales Representative Salary Survey Data, Economic Research Institute (Apr. 29, 2009),
http://www.erieri.com/index.cfm?fuseaction=research.Pharmaceutical-Sales-Representatives (comparing salaries
for Charlotte, North Carolina, Orlando, Florida, Phoenix, Arizona, Indianapolis, Indiana, Dallas, Texas, Atlanta,
Georgia, Manhattan, New York, Houston, Texas, Los Angeles, California and Chicago, Illinois).
13.
See, e.g., Clint Cora, Starting Salary and Income Ranges for Pharmaceutical Drug Sales Representatives
(June
6,
2007),
http://www.yoursdaily.com/layout/set/print/money/starting_salary_and_income_ranges_for_pharmaceutical_drug
_sales_representatives. Accord Mack, supra note 10 (average total compensation in 2007 for pharmaceutical sales
representatives was $94,200 which would be higher than the average salary).
14.
Fair Labor Standards Act, Pub. L. No. 75-718, Ch. 676, 52 Stat. 1060 (1938) (codified at 29 U.S.C. §§
201-19).
15.
29 U.S.C. § 202.
16.
See 29 U.S.C. §§ 206, 207 (providing for minimum wage and overtime).
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are entitled to a minimum hourly wage for each hour worked 17 and at least one and
one-half times an employee’s regular wage rate for hours worked over forty in a
given workweek. 18 According to the Department of Labor, the minimum wage and
overtime pay requirements are “among the nation’s most important worker protections.”19
The FLSA also contains various exemptions from the overtime requirement
for, among others, executive, professional, and administrative workers, and outside
salespersons. 20 These “exemptions” cover millions of workers. 21 As a matter of
law, these exemptions are to be narrowly construed against the employer seeking to
assert them and will be limited to those workers “plainly and unmistakably” within
the exemptions’ “terms and spirit.”22 The burden of invoking these exemptions
rests with the employer.23 According to the Department of Labor:
The legislative history [of the Fair Labor Standards Act] indicates
that [the Act’s] exemptions were premised on the belief that the
workers exempted typically earned salaries well above the minimum wage, and they were presumed to enjoy other compensatory
privileges such as above average fringe benefits and better opportunities for advancement setting them apart from the nonexempt
workers entitled to overtime pay. Further, the type of work they
performed was difficult to standardize to any time frame and could
not easily be spread to other workers after 40 hours in a week,
making compliance with the overtime provisions difficult and generally precluding the potential job expansion intended by the
FLSA’s time-and-a-half overtime premium. 24
Of particular relevance to overtime claims brought by pharmaceutical sales
representatives are the exemptions for outside salespersons and administrative employees.25
________________________

17.
See 29 U.S.C. § 206 (providing that presently the minimum hourly wage is $7.25 under the FLSA).
18.
29 U.S.C. § 207.
19.
Dep’t of Labor, Wage & Hour Div., Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales and Computer Employees; Final Rule, 69 Fed. Reg. 22122, 22123 (Apr. 23,
2004) [hereinafter Final Rule].
20.
29 U.S.C. §213(a)(1) (2009). The exemption for executive, professional and administrative employees
is commonly referred to as the “white-collar exemptions.” See, e.g., Scott D. Miller, Revitalizing the FLSA,
HOFSTRA LAB. & EMPL. L.J. 1 (2001) (providing a comprehensive discussion of the FLSA and its history).
21.
Peter Romer-Friedman, Eliot Spitzer Meets Mother Jones: How State Attorneys General Can Enforce
State Wage and Hour Laws, 39 COLUM . J.L. SOC . PROBS. 495, 501 (2006).
22.
Arnold v. Ben Kanowsky, Inc., 362 U.S. 388, 392 (1960); Davis v. Mountaire Farms, Inc., 453 F.3d
554, 556 (3d Cir. 2006); Bilyou v. Dutchess Beer Distribs., Inc., 300 F.3d 217, 222 (2d Cir. 2002).
23.
Bilyou, 300 F.3d at 222.
24.
Final Rule, supra note 19, at 22123-24.
25.
Compare Ruggeri v. Boehringer Ingelheim Pharms., Inc., 585 F. Supp. 2d 254 (D. Conn. 2008) (finding sales representatives to be non-exempt and therefore covered by the FLSA’s overtime provisions) with In re
Novartis Wage & Hour Litig., 593 F. Supp. 2d 637 (S.D.N.Y. 2009) (concluding that sales representatives are
exempt from the FLSA’s overtime provisions both as outside salesmen and administrative employees).
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OUTSIDE SALESMAN EXEMPTION
Employers are granted an exemption from the FLSA’s overtime requirements
for outside salespersons as that term is defined by the Department of Labor’s regulations. 26 Because the FLSA grants the Secretary of Labor the broad authority to
define and delimit the exemptions to the statute’s overtime requirements, the regulations have the force of law and will be controlling unless found to be arbitrary,
capricious, or manifestly contrary to the statute. 27 The Department of Labor also
promulgates regulations setting forth the Secretary’s position on how the regulations should be applied. These interpretations, although lacking the force of law,
may be relied upon for guidance by courts and litigants. 28
The purpose of the outside sales exemption was explained by the United States
Court of Appeals for the Tenth Circuit sixty years ago in Jewel Tea Co. v. Williams:
[The] salesman, to a great extent, work[s] individually. There are
no restrictions respecting the time he shall work and he can earn as
much or as little, within the range of his ability, as his ambition
dictates. In lieu of overtime, he ordinarily receives commissions
as extra compensation. He works away from his employer’s place
of business, is not subject to the personal supervision of his employer, and his employer has no way of knowing the number of
hours he works per day.29
The standard for whether an employee is exempt as an outside salesman is
whether an employee’s:
(1) primary duty is:
(i) making sales as that term is defined in section 3(k) of the Act
or
(ii) obtaining orders or contracts for services or for the use of facilities for which a consideration will be paid by the client or customer; and

________________________

26.
29 U.S.C. § 213(a)(1). See generally Allan J. Schwartz, Who is employed in “capacity of outside
salesman” within the meaning of § 13(a)(1) of Fair Labor Standards Act (29 U.S.C.A. § 213(a)(1)), as amended,
exempting such employees from minimum wage and overtime requirements of Act, 26 A.L.R. FED. 941 (1976).
27.
Freeman v. NBC, Inc., 80 F.3d 78, 82 (2d Cir. 1996).
28.
Skidmore v. Swift & Co., 323 U.S. 134 (1944). See also Roth v. Perseus, LLC, 522 F.3d 242, 247-48
(2d Cir. 2008) (stating that interpretations of regulations are given deference unless plainly erroneous or inconsistent with statutes or regulations).
29.
Jewel Tea Co. v. Williams, 118 F.2d 202, 207-08 (10th Cir. 1941).
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(2) who is customarily and regularly engaged away from the employer’s place of business in performing the primary duty. 30
The Act defines a “sale” to include “any sale, exchange, contract to sell, consignment for sale, shipment for sale, or other disposition.”31 The related regulations include in this definition the “transfer of title to tangible property, and in certain cases, of tangible and valuable evidences of intangible property.”32
The regulations also distinguish between promotional and sales work. 33 Promotional work actually performed incidental to, and in conjunction with, an employee’s own outside sales or solicitations is exempt. 34 Promotional work that is
incidental to sales made, or to be made, by someone else, however, is not exempt. 35
Examples of promotional work incidental to sales include a manufacturer’s representative who visits a customer’s shop for the purpose of putting up displays and
posters, removing damaged or spoiled stock from the merchant’s shelves, or rearranging the merchandise. 36 By way of illustration, in 1999 the Department of Labor issued an opinion letter concluding that college recruitment counselors are not
exempt as outside salespersons because they do not make sales of a college’s services, or obtain contracts for those services. 37 This is because such work involves
identifying customers, in this scenario students, which may lead to an application.
This is because such work involves identifying customers, which in this scenario
refers to students, which may lead to an application. 38
If the employee at issue makes at least some sales or obtains some orders or
contracts, then the outside sales exemption may apply, provided that such work
constitutes the employee’s primary duty.39 The primary duty is the “principal,
main, major or most important duty that the employee performs.”40 The determination is made based on all the facts of a case with emphasis on the character of the
job as a whole,41 although the time spent performing exempt work is a relevant
guide. 42 Relevant factors include whether the job was advertised as a sales job,
whether the employees were referred to as salespeople, whether they were provided
with sales training, whether the employees received commissions, and whether
________________________

30.
29 C.F.R. § 541.500(a) (2004).
31.
29 U.S.C. § 203(k) (2009).
32.
29 C.F.R. § 541.501(b) (2004).
33.
29 C.F.R. § 541.503(a) (2004).
34.
Id.
35.
Id.
36.
29 C.F.R. § 541.503(b).
37.
Opinion Letter No. 2138 (Apr. 20, 1999), 1999 DOLWH LEXIS 45.
38.
Id.
39.
The Department of Labor has stated that it would be improper to extend the outside sales exemption to
someone who does not “in some sense make a sale.” Dep’t of Labor, Wage & Hour Public Contracts Div., Report
and Recommendation of the Presiding Officer on Proposed Revisions of Regulations (Oct. 10, 1940) at 46. See
also Final Rule, supra note 19, at 22162 (the exemption should apply only where the employee “in some sense,
has made sales”).
40.
29 C.F.R. § 541.700(a).
41.
Id.
42.
29 C.F.R. § 541.700(b).
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they operated independently. 43 All work that is “incidental to and in conjunction
with the employee’s own outside sales or solicitations” and all work that furthers
the employee’s sales efforts must also be considered exempt outside sales. 44 Initially, the inquiry focuses on whether the employee’s primary duty is to make actual sales. 45
ADMINISTRATIVE EMPLOYEES
Also relevant to the pharmaceutical sales representatives’ claims for overtime
is whether these employees qualify as administrative employees and are therefore
exempt. The FLSA exempts from coverage “any employee employed in a bona
fide . . . administrative . . . capacity.”46 To qualify, the employee must earn more
than $455 per week and his or her primary duties must include: (1) non-manual
work directly related to the management or general business operations of the employer or the employer’s customers, and (2) the exercise of “discretion and independent judgment” with respect to “matters of significance.” 47 With respect to the
first prong of the test, the work must be “directly” related to management or general business operations. 48 Work that is only indirectly or tangentially related to administrative functions will not be considered exempt. 49 The inquiry has two parts
which consider both the type of work at issue and the level or nature of that work. 50
In order to satisfy the first prong of the test, the employee has to “perform
work directly related to assisting with the running or servicing of the business, as
distinguished, for example, from working on a manufacturing production line or
selling a product in a retail service establishment.” 51 Advisory language from the
Department of Labor in 2004 recognizes:
As explained in the 1949 Weiss Report, the administrative operations of the business include the work of employees “servicing”
the business, such as, for example, “advising the management,
planning, negotiating, representing the company, purchasing, promoting sales, and business research and control.” As the current
regulations state at section 541.205(c), exempt administrative work
________________________

43.
Edwards v. Alta Colleges, Inc., No SA-03-CA-0538 OG (NN), 2005 U.S. Dist. LEXIS 3753, at 30
(W.D. Tex. 2005); Nielsen v. Devry, Inc., 302 F. Supp. 2d 747, 756-58 (W.D. Mich. 2003). See, e.g., Hodgson v.
Klages Coal & Ice Co., 435 F.2d 377, 382-84 (6th Cir. 1970); Wirtz v. Charleston Coca Cola Bottling Co., 356
F.2d 428, 429-30 (4th Cir. 1966); Wirtz v. Atlanta Life Ins. Co., 311 F.2d 646, 648 (6th Cir. 1963); Jewel Tea Co.,
118 F.2d at 208; Olivo v. GMAC Mortgage Corp., 374 F. Supp. 2d 545, 550 (E.D. Mich. 2004); Fields v. AOL
Time Warner, Inc., 261 F. Supp. 2d 971, 975 (W.D. Tenn. 2003); Hodgson v. Krispy Kreme Doughnut Co., 346 F.
Supp. 1102, 1104-07 (M.D.N.C. 1972); Bradford v. Gaylord Prods., Inc., 77 F. Supp. 1002, 1004-05 (N.D. Ill.
1948); Nunneley v. Farmers Ins. Exch., 564 P.2d 231, 235 (Okla. 1977).
44.
29 C.F.R. § 541.500(b).
45.
Ackerman v. Coca-Cola Enters., Inc., 179 F.3d 1260, 1265 (10th Cir. 1999).
46.
29 U.S.C. § 213(a)(1).
47.
29 C.F.R. § 541.200(a).
48.
Final Rule, supra note 19, at 22137.
49.
Id.
50.
Final Rule, supra note 19, at 22144.
51.
29 C.F.R. § 541.201(a).
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includes not only those who participate in the formulation of management policies or in the operation of the business as a whole, but
it “also includes a wide variety of persons who either carry out major assignments in conducting the operations of the business, or
whose work affects business operations to a substantial degree,
even though those assignments are tasks related to the operation of
a particular segment of the business.”52
The exemption covers a wide variety of workers who carry out major assignments in operating the business or those whose work affects operations to a substantial degree. 53 The Department of Labor has characterized such work as including:
but not limited to, work in functional areas such as tax; finance;
accounting; budgeting; auditing; insurance; quality control; purchasing; procurement; advertising; marketing; research; safety and
health; personnel management; human resources; employee benefits; labor relations; public relations; government relations; computer network, internet and database administration; legal and regulatory compliance; and similar activities. 54
The administrative/production distinction, however, is only one tool for determining the applicability of the exemption and will be dispositive only where the
work involved “falls squarely on the production side of the line.” 55 The inquiry is
fact specific and requires analysis of statutory and regulatory frameworks as a
whole.56
With respect to the second prong of the test, the Department of Labor defines
the exercise of discretion and independent judgment as the “comparison and the
evaluation of possible courses of conduct, and acting or making a decision after the
various possibilities have been considered.”57 Here, the term “matters of significance” addresses the level of importance of the work at issue or the consequence of
________________________

52.
Final Rule, supra note 19, at 22138.
53.
Id.
54.
29 C.F.R. § 541.201(b).
55.
Final Rule, supra note 19, at 22141 (“We do not believe that it is appropriate to eliminate the concept
entirely from the administrative exemption but neither do we believe that the dichotomy has ever been or should
be a dispositive test for exemption”). See Bothell v. Phase Metrics, Inc., 299 F.3d 1120, 1127 (9th Cir. 2002)
(quoted in Department of Labor position). That being said, some courts have nevertheless used the administrative/production dichotomy as a determinative factor in their analysis. See, e.g., Reich v. John Alden Life Ins. Co.,
126 F.3d 1, 9 (1st Cir. 1997) (insurance marketers employed by company producing and marketing insurance
policies were engaged in administrative work because they “are no way involved in the design or generation of
insurance policies, the very product that the enterprise exists to produce and market”); Martin v. Cooper Elec.
Supply Co., 940 F.2d 896, 903 (3d Cir. 1991) (sales employees working for electrical parts wholesaler were engaged in production work because employer’s business purpose was to produce sales of electrical products, the
work that the employees did).
56.
Phase Metrics, 299 F.3d at 1127; Webster v. Pub. Sch. Employees of Wash., Inc., 247 F.3d 910, 916
(9th Cir. 2001).
57.
29 C.F.R. § 541.202(a).
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that work. 58 The Department of Labor’s non-exclusive list of factors to consider
includes whether the employee:
• has authority to formulate, affect, interpret, or implement management policies or operating practices;
• carries out major assignments in conducting the operations of the
business;
• performs work that affects the business operations to a substantial degree, even if the employee’s assignments are related to the
operation of a particular segment of the business;
• has authority to commit the employer in matters that have significant financial impact;
• has authority to waive or deviate from established policies and
procedures without prior approval;
• has authority to negotiate and bind the company on significant
matters;
• is involved in planning long- or short-term business objectives;
• investigates and resolves matters of significance on behalf of
management; and/or
• represents the company in handling complaints, arbitrating disputes or resolving grievances.59
The list includes those activities “clearly related to servicing the business itself” and without which the employer “could not function.”60 This list does not
include activities centering on what the business at issue specifically sells or provides. Rather, these are tasks that every business must engage in to function. 61
This requirement is met when the employee engages in running the business itself
or determining its overall course or policies as opposed to the day-to-day carrying
out of affairs.62
When two or three of these factors are met, the courts will generally find that
the employee at issue is exercising discretion and independent judgment sufficient
________________________
58.
59.
60.
61.
62.

Id.
29 C.F.R. § 541.202(b).
Neary v. Metro. Prop. & Cas. Ins. Co., 517 F. Supp. 2d 606, 614 (D. Conn. 2007).
Id.
Phase Metrics, 299 F.3d at 1125.

https://lawpublications.barry.edu/barrylrev/vol13/iss1/1

8

: Fair Labor Standards and the Pharmaceuticals Industry

Fall 2009

Fair Labor Standards and the Pharmaceuticals Industry

9

to invoke the exemption. 63 When considering this test, it is important to note that
use of well-established techniques, procedures, and specific standards in manuals
or other sources will not qualify to satisfy the second prong of the test. 64 The employee must have the authority to make an independent choice without immediate
direction or supervision. 65
This requirement may be satisfied even if there is review at a higher level. 66
Accordingly, the exercise of independent judgment does not require that the decisions the employee makes have the type of finality that goes with unlimited authority and absence of review. 67 The authority may consist of making recommendations for action rather than actually taking action. 68
The Department of Labor also recognizes that many employees in the same
business may qualify for this exemption. 69 It is up to the employer to establish that
this test has been satisfied in order for the exemption to apply. 70
It should be noted that in 1945, the Department of Labor issued an Opinion
Letter concluding that “medical detailists” employed by pharmaceutical companies
are exempt from overtime coverage as administrative employees. 71 The work involved increasing the “use of subject’s product in hospitals and through physicians’
recommendations.”72 According to the Department, this work required a “high
degree of technical knowledge.”73 The detailists’ duties were to:
train personnel, make special surveys and reports, and in general
maintain th[e] company’s relations with the medical and associated
professions. They are consulted with respect to individual nutri________________________

63.
Final Rule, supra note 19, at 22143 (citing Bondy v. City of Dallas, 77 Fed. Appx. 731 (5th Cir. 2003))
(making recommendations to management on policies and procedures); McAllister v. Transamerica Occidental
Life Ins. Co., 325 F.3d 997, 1000-02 (8th Cir. 2003) (independent investigation and resolution of issues without
prior approval and authority to waive or deviate from established policies and procedures without approval);
Cowart v. Ingalls Shipbuilding, Inc., 213 F.3d 261, 267 (5th Cir. 2000) (developing guidebooks, manuals, and
other policies and procedures for employer or the employer’s customers); Haywood v. N. Am. Van Lines, Inc.,
121 F.3d 1066, 1071-73 (7th Cir. 1997) (negotiating on behalf of the employer with some degree of settlement
authority and independent investigation and resolution of issues without prior approval); O’Neill-Marino v. Omni
Hotels Mgmt. Corp., 2001 WL 210360 *8-9 (S.D.N.Y. 2001) (negotiating on behalf of the employer with some
degree of settlement authority and developing guidebooks, manuals, and other procedures and policies for employer or the employer’s customers); Stricker v. E. Off-Rd. Equip., Inc., 935 F. Supp. 650, 656-59 (D. Md. 1996)
(authority to commit employer in matters that have financial impact); Reich v. Haemonetics Corp., 907 F. Supp.
512, 517-18 (D. Mass. 1995) (negotiating on behalf of the employer with some degree of settlement authority and
authority to commit employer in matters that have financial impact); Hippen v. First Nat’l Bank, 1992 WL 73554
*6 (D. Kan. 1992) (authority to commit employer in matters that have financial impact).
64.
29 C.F.R. § 541.202(e).
65.
29 C.F.R. § 541.202(c).
66.
Id.
67.
Id.
68.
Id. For a summary of these requirements, see Employment Standards Administration, Wage and Hour
Division, U.S. Dep’t of Labor, Fact Sheet #17F: Exempt Outside Sales Employees Under Fair Labor Standards
Act (FLSA) (Rev. July 2008).
69.
29 C.F.R. § 541.202(d).
70.
Final Rule, supra note 19, at 22144.
71.
See Applicability of Exemption for Administrative Employees to Medical Detailists, 1943-48 WAGESHOURS LAB. L. REP. (CCH) ¶ 33,093 (May 19, 1945).
72.
Id.
73.
Id.
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tional problems encountered by hospitals and physicians, such as
determining whether the use of subject’s product in a hospital was
related to the occurrence of an epidemic. When necessary, they arrange for added deliveries of subject’s product to take care of
emergencies. They instruct the firm’s salesmen in such technical
matters as disease prevention, the chemical components of their
product and nutritional research. They work virtually without supervision. . . .74
Based on these responsibilities, the Department of Labor concluded that the
medical detailists were involved in matters related to general business operations
requiring the use of discretion and independent judgment informed by special training and experience. 75 Accordingly, medical detailists were exempt from the Act’s
overtime requirements.76
THE OVERTIME ANALYSIS AND PHARMACEUTICAL SALES REPRESENTATIVES
Court analysis of whether pharmaceutical sales representatives are entitled to
overtime pay under the FLSA begins with a cluster of court decisions issued by the
federal district court in the Central District of California addressing whether the
sales representatives are exempt from overtime requirements under the California
Labor Law’s exemption for outside sales representatives. 77 The facts underlying
the cases are similar.
In Barnick v. Wyeth, the plaintiff was hired into Wyeth’s sales staff. 78 His essential job function was to “effect sales by educating and guiding health care professionals in their purchase and prescription of Wyeth products and by promoting
treatment practices that are consistent with approved indications.” 79 This central
job duty is consistent across the industry.80
________________________

74.
Id.
75.
Id. See Cote v. Burroughs Wellcome Co., 558 F. Supp. 883, 887 (E.D. Pa. 1982) (pharmaceutical
company detail person exempt under the FLSA as administrative employee).
76.
Id.
77.
See Menes v. Roche Labs, Inc., No. 2:07-cv-01444-ER-FFMx, 2008 U.S. Dist. LEXIS 4230 (C.D. Cal
Jan. 7, 2008); D’Este v. Bayer Corp, No. CV 07-3206-JFW(PLAx), 2007 U.S. Dist. LEXIS 87229 (C.D. Cal. Oct.
9, 2007); Barnick v. Wyeth, 522 F. Supp. 2d 1257 (C.D. Cal. 2007). See also Yacoubian v. Ortho-McNeil, Inc.,
No. 07-00127, 2009 U.S. Dist. LEXIS 27937 (C.D. Cal. Feb. 6, 2009); Delgado v. Ortho-McNeil, Inc., No. 0700263, 2009 U.S. Dist. LEXIS 28810 (C.D. Cal. Feb. 6, 2009); Rivera v. Schering Corp., No. CV 08-1743GW(JCx), 2008 U.S. Dist. LEXIS 111105 (C.D. Cal. Aug. 14, 2008).
78.
Barnick, 522 F. Supp. 2d at 1258.
79.
Id.
80.
See, e.g., Menes, 2008 U.S. Dist. LEXIS 4230, at *3 (The Sales Representative’s job is “to inform
medical personnel about Defendant’s drugs in the hope that they will prescribe Roche products to their patients.”);
D’Este, 2007 U.S. Dist. LEXIS 87229, at *1 (“[P]harmaceutical representatives . . . are responsible for promoting
and selling Bayer’s prescription pharmaceutical products to medical care providers, including primary care physicians, specialists, and hospitals.”). See also Amendola, 558 F. Supp. 2d at 463-64 (“PRs are required to be in the
field visiting medical providers from 8 a.m. to 5 p.m., and spend time in the evenings preparing for these visits.
The goal of the visits is to influence the prescription practices of the providers.”); In re Novartis, 593 F. Supp. 2d
at 641 (“The primary function of the Reps is calling on physicians and giving them information about NPC’s
drugs.”); Ruggeri, 585 F. Supp. 2d at 258 (“Plaintiffs’ job duty was, centrally, to visit physicians and pharmacies
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Barnick’s responsibilities included calling physicians pre-assigned to a specific
list to discuss Wyeth’s pharmaceutical products, in this case two vaccines, Prevnar
and FluMist, and two drugs, Altace and Protonix. 81 He spent, on average, between
forty-five and forty-eight hours each week in the field and had a specific number of
doctors he needed to see within a specified time period and a daily quota of calls to
make. 82 Although his hours were not controlled, and he was rarely subject to direct
supervision, the plaintiff was expected to work from 8:30 am to 5:00 pm and to log
physician calls daily, file various reports, check his voicemail three times each day,
and synchronize his computer once each day. 83
Barnick did not, however, sell products directly to physicians. 84 Occasionally,
he provided order forms for vaccines, and sometimes he filled them out. 85 The
doctors would then order the vaccines from Wyeth and prescribe and administer
the vaccines to patients, or prescribe drugs which would then be ordered through a
pharmacy.86
The plaintiff referred to himself as a “salesperson” and was trained in sales
techniques at numerous conferences throughout his employment where managers
discussed sales data and sales strategies. 87 He was paid a yearly salary and received additional compensation tied into the sales he assisted in generating.88 Further, half of Barnick’s evaluation was based on meeting sales objectives for
Wyeth’s products.89 The facts in this case are similar to those in D’Este v. Bayer
Corporation90 and Menes v. Roche Laboratories, both of which, as set forth above,
were decided in the same judicial district.91
The plaintiffs in each case filed suit claiming, among other things, that they
were never paid overtime under California’s Labor Code. 92 Like the FLSA, the
California Labor Code and the state Industrial Welfare Commission (“IWC”) provide that outside salespersons are exempt from the state’s overtime requirements. 93
According to the IWC, an outside salesperson is “any person, 18 years or over,
who customarily and regularly works more than half the working time away from
the employer’s place of business selling tangible or intangible items or obtaining
orders or contracts for products, services or use of facilities.” 94 The California
in an assigned geographical territory and present information about, and samples of, Boehringer pharmaceutical
products.”).
81.
Barnick, 522 F. Supp. 2d at 1258.
82.
Id.
83.
Id.
84.
Id.; In re Novartis, 593 F. Supp. 2d at 642 (In fact, the sales representatives are prohibited from selling
drugs directly to physicians.).
85.
Barnick, 522 F. Supp. 2d at 1258-59.
86.
Id. at 1259.
87.
Id.
88.
Id.
89.
Id.
90.
D’Este, 2007 U.S. Dist. LEXIS 87229, at *1-3 (setting forth allegations).
91.
Menes, 2008 U.S. Dist. LEXIS 4230, at *2.
92.
Barnick, 552 F. Supp. 2d. at 1260 (citing C AL. LAB. CODE § 510 (Deering 2009)); D’Este, 2007 U.S.
Dist. LEXIS 87229, at *3; Menes, 2008 U.S. Dist. LEXIS 4230, at *2-3.
93.
CAL. LAB . CODE § 1171; IWC Wage Order No. 4-2001(1)(C), C AL. CODE REGS. tit. 8, § 11070 (2009).
94.
IWC Wage Order No. 4-2001(2)(M), available at http://www.dir.ca.gov/IWC/IWCArticle4.pdf.
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analysis is quantitative and focuses on whether the employee spends more than
fifty percent of his or her time in sales activities. 95 In Barnick, the court reasoned
that the California exemption is similar to the FLSA exemption in that exempt outside salespersons under both statutes are those generally able to set their own schedules and are generally on the road, without the employer knowing what they are
doing on an hourly basis.96 As a result, it is difficult to control their hours or working conditions.97
Recognizing case law under the FLSA as persuasive authority, 98 and applying
the factors collected from other FLSA cases, the court concluded that the plaintiffpharmaceutical sales representative was exempt from California state overtime
requirements as an outside salesperson because he was hired on the basis of his
sales experience, to a position which both sides referred to as a sales position, he
received specialized sales training at sales conferences, his pay was determined in
part by the sales he generated, he had virtually no direct or constant supervision,
and he occasionally solicited business.99 Further, the plaintiff, although subject to
quotas and assigned to a pre-determined list of physicians, was free to decide
which physician to see and when. 100 Accordingly, the court determined summary
judgment for the defendant was appropriate.101
In reaching this conclusion, the court found “unpersuasive” that the sales representative dealt with physicians rather than the end purchasers of the drugs being
sold. 102 According to the court, because the doctors “control” the product’s ultimate purchase through their prescriptions, to conclude that the sales representatives
are exempt would elevate the form of the salespersons’ work over its substance. 103
The court further concluded that while the Department of Labor’s interpretation of
the FLSA distinguishes between promotional and sales work based on whether the
employee obtained some type of commitment for sales, this reasoning was unpersuasive, and so the court declined to apply it under the California Labor Law. 104
Moreover, the fact that the employee’s work did not immediately result in some
sort of commitment to buy was of no moment, especially where there was no other
employee who reached out to confirm the sale. 105 Rather, this distinction better
rested on whether the employees’ efforts were addressed to the general public ra________________________

95.
Barnick, 522 F. Supp. 2d at 1261 (citing Ramirez v. Yosemite Water Co., Inc., 978 P.2d 2, 9 (Cal.
1999)).
96.
Id.
(citing
Cal.
DLSE,
Opinion
Letter,
Sept.
8,
1998,
available
at
http://www.dir.ca.gov/dlse/opinions/1998-09-08.pdf).
97.
Id.
98.
Id. at 1262-63 (citing Monzon v. Schaefer Ambulance Serv., Inc., 273 Cal. Rptr. 615, 623 (Cal. Ct.
App. 1990); Nordquist v. McGraw-Hill Broad. Co., 38 Cal. Rptr. 2d 221, 225 (Cal. Ct. App. 1995) (recognizing
the interpretations of the federal statute as persuasive authority)).
99.
Barnick, 522 F. Supp. 2d at 1262-63 (citing Nielsen v. Devry, Inc., 302 F. Supp. 2d 747, 756-58 (W.D.
Mich. 2003) (listing relevant factors)).
100.
Id. at 1263.
101.
Id. at 1265.
102.
Id. at 1264.
103.
Barnick, 522 F. Supp. 2d at 1264.
104.
Id.
105.
Id. at 1265
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ther than an individual.106 The D’Este and Menes courts reached the same conclusion applying similar reasoning.107
In the D’Este case, the litigants also presented the issue as to whether the sales
representatives qualified as administrative employees, and were, therefore, exempt
from the state overtime requirements under an alternative theory. 108 Because the
district court found that the employees were outside salespersons, however, the
issue was never decided. 109
On May 5, 2009, the United States Court of Appeals for the Ninth Circuit in
the D’Este case, which was consolidated with Menes and Barnick for the purposes
of appeal, certified two questions to the Supreme Court of California:
1. [Under the Industrial Welfare Commission’s Wage Orders]
[d]oes a pharmaceutical sales representative (PSR) qualify as an
“outside salesperson” under [the] definition [above], “if the PSR
spends more than half the working time away from the employer’s
place of business and personally interacts with doctors and hospitals on behalf of drug companies for the purpose of increasing individual doctors’ prescriptions of specific drugs?”
2. “In the alternative, Wage Order 4-2001 defines a person employed in an administrative capacity as a person whose duties and
responsibilities involve (among other things) ‘[t]he performance of
office or non-manual work directly related to management policies
or general business operations of his/her employer or his employer’s customers’ and ‘[w]ho customarily and regularly exercises
discretion and independent judgment.” . . . Is a PSR, as described
above, involved in duties and responsibilities that meet these requirements?110
In certifying Question 1, the Court of Appeals expressly noted that while interpretation of the FLSA may be relevant to the analysis of the IWC’s interpretation
of the outside sales exemption, any assistance in this regard “may be limited” because the IWC’s exemption language does not closely track the language of the
analogous federal regulations.111 In certifying Question 2, the appellate court recognized that the administrative employee exemption under California law is to be
treated in the same manner as the FLSA regulations. 112
________________________

106.
Id.
107.
D’Este, 2007 U.S. Dist. LEXIS 87229, at *13-16 (also relying on cases decided under the FLSA as
persuasive authority); Menes, 2008 U.S. Dist. LEXIS 4230, at *3-7 (adding as a factor that the plaintiff in that case
could identify and solicit physicians on her own).
108.
D’Este, 2007 U.S. Dist. LEXIS 87229, at *16.
109.
Id.
110.
D’Este v. Bayer Corp., 565 F.3d 1119, 1120-21 (9th Cir. 2009).
111.
Id. at 1124 (citing Ramirez, 978 P.2d at 9-10).
112.
Id. at 1125 (citing C AL. CODE REGS. tit. 8 § 11040).
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In the interim, while these cases are working their way through the appellate
process, the California district court decisions have received mixed reviews in subsequent cases. In In re Novartis Wage and Hour Litigation, Judge Crotty in the
federal district court for the Southern District of New York came to a similar conclusion on summary judgment when considering claims brought under the FLSA,
California Labor Law and New York wage and hour law. Initially, the Novartis
court decided the issue under the FLSA and New York law without reference to the
California decisions despite the fact that those decisions relied on an FLSA analysis.113 Here, the central issue was framed as whether the sales representatives were
exempt because they actually executed “sales” within the meaning of the Act, or
instead, engaged merely in non-exempt promotional activities. 114 This analysis is
different than that applied by the California cases which focused more on other
indicia, such as job title, past sales experience necessary to obtain the job, the nature of the job training, and whether compensation was on a commission basis.115
In answering this question in the affirmative, the New York district court first
acknowledged the policy animating the outside sales exemption as explained by the
Tenth Circuit:
Jewel Tea teaches that outside salespersons are exempt from the
overtime requirement not because they “sell,” as that term is technically defined, but rather because they (1) generate commissions
for themselves through their work and (2) work with minimal supervision, making adherence to an-hours based compensation
scheme impractical. The Jewel Tea rationale is echoed in the
DOL’s 2004 Final Rule, which notes that the “white collar” exemptions owe their existence to the fact that the employees they
were meant to cover “typically earned salaries well above the minimum wage, and they were presumed to enjoy other compensatory
privileges such as above average fringe benefits and better opportunities for advancement. . . . The DOL Final Rule also recognizes
that the work done by these employees “was difficult to standardize to any time frame . . . making compliance with the overtime
provisions difficult.”116
Applying this policy, the court then began its inquiry into whether the plaintiffs
were actually engaged in sales. 117 In starting its analysis, the court recognized that
any review required examination of the industry at issue. 118 In particular, the court
________________________

113.
In re Novartis, 593 F. Supp. 2d at 648-53.
114.
Id. at 648, 651.
115.
See supra notes 98-101 and accompanying text.
116.
In re Novartis, 593 F. Supp. 2d at 649.
117.
Id.
118.
Id. (citing Nielsen, 302 F. Supp. 2d at 755-56 (addressing the exemption in the context of the college
admissions process); Gregory v. First Title or Amer., Inc., No. 06-Civ.-1746, 2008 WL 150487 (M.D. Fla. Jan. 14,
2008) (addressing the exemption in the context of the title insurance industry where the plaintiff could not sell the
insurance herself was nevertheless exempt because she “obtained orders”), aff’d, 555 F.3d 1300 (11th Cir. 2009)).
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drew on a footnote from an earlier Minnesota decision that took place in the context of the medical devices industry, Medtronic, Inc. v. Gibbons.119 In Medtronic,
an employment contract case, the court noted that pacemakers are ultimately consumed by patients, not doctors or hospitals to which they are sold. 120 Nevertheless,
the sale was based on a physician recommendation, and so sales efforts are focused
on doctors and medical personnel. 121 As a result, the court in Medtronic reasoned
that the term “customers” must include not only the hospital that pays for the product, but also the doctors who recommend its purchase. 122
Similarly, reasoned the Novartis court, the physicians who prescribe pharmaceuticals are, in reality, the ones who control the purchase of the drugs by writing
prescriptions.123 Without the prescriptions, no sales can take place. 124
Plaintiffs argue that “[Novartis] sells drugs to distributors. Distributors sell drugs to pharmacies. Pharmacies sell drugs to individuals.” . . . In other words, Plaintiffs ask this Court to conclude
that the only true sales made by [Novartis] are to distributors. The
Court cannot ignore reality. Distributors are not the end-users of
[Novartis’s] products. If physicians did not prescribe [Novartis’s]
products, patients would be unable to buy them and distributors
would have no incentive to make purchases from [Novartis]. The
purchase cycle commences with a prescription from physicians,
who are therefore the appropriate target of the Reps’ sales efforts.
When the physician writes a prescription for the [Novartis] product, then a sale can take place. Without prescriptions, patients cannot buy the drugs and there is no sale. 125
The fundamental nature of this relationship is highlighted by the fact that Novartis spends in excess of $500 million annually to have its sales representatives
meet with physicians to get them to prescribe company products. 126
This reasoning was subsequently endorsed and elaborated upon in the federal
district court for the Western District of Pennsylvania in Baum v. Astrazeneca
LP.127 In that case, which was brought under Pennsylvania state wage and hour
law, the court noted that the markets for pharmaceuticals and medical services do
not function like typical markets. 128 This is due, at least in part, to the “profession________________________

119.
Medtronic, Inc. v. Gibbons, 527 F. Supp. 1085 (D. Minn. 1981), aff’d, 684 F.2d 565 (8th Cir.1982)
(explaining sales in contract case).
120.
Id. at 1094 n.3.
121.
Id.
122.
Id.
123.
In re Novartis, 593 F. Supp. 2d at 650.
124.
Id. at 650-51.
125.
Id.
126.
Id. at 650.
127.
Baum v. Astrazeneca LP, 605 F. Supp. 2d 669 (W.D. Pa. 2009).
128.
Id. at 675. Pennsylvania state law contains exemptions from coverage for outside salespeople and
administrative employees. See 34 PA. CODE § 231.83 (2009) (administrative employees); PA. CONS. STAT. §
333.105(a)(5) (2009) (outside salesman).
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al culture of physicians” who operate under what is sometimes referred to as a
“professional paradigm.”129 In this situation, regulation and professional ethics
substitute for the workings of a free market, with physicians acting as substitute
decision makers, rather than sources of education or advice for consumers. 130 The
physicians’ decisions are made based on unbiased science. 131 Because the doctors
possess knowledge generally inaccessible to lay-people, they control the decision
making. 132
This role of doctors as substitute decision-makers emerged concomitant to the belief that patients themselves are incapable of understanding sufficient information to make intelligent medical decisions [footnote omitted]. In other words, the information asymmetry between physician and patient is simply a bridge too far: because only physicians have the extensive required scientific knowledge and training to make informed health care choices, they
alone, must make medical decisions, as patients simply could not
possibly make wise decisions for themselves. This pure professional paradigm empowers physicians and subordinates individual
consumer preference and choice. 133
In reaching its conclusion, the Novartis court characterized the plaintiffs’ argument that the sales representatives’ work was non-exempt “promotional” work
rather than “sales” work as “simply wrong.” 134 This is because the Department of
Labor’s distinction between exempt sales work and non-exempt promotional work
is invoked only where the promotional work is incidental to sales made by other
employees as opposed to themselves, the latter being the situation in the pharmaceuticals industry where it is clear from the compensation structure that the sales
representatives’ work is to generate sales for themselves. 135 This is because their
work, namely visiting physicians to generate sales, is tantamount to obtaining a
commitment to buy, which the Department of Labor considers exempt. 136 Further,
the sales representatives have the independence typically associated with outside
________________________

129.
Id. at 679-80 (“[T]he Court believes that the professional paradigm still accurately describes much of
the actual practices of the health services industry.”); Clark C. Havighurst, The Professional Paradigm of Medical
Care: Obstacle to Decentralization, 30 JURIMETRICS J. 415, 419-21 (1990).
130.
Id. at 678 (citing James F. Blumstein, Healthcare Reform and Competing Visions of Medical Care:
Antitrust and State Provider Cooperation Legislation, 79 CORNELL L. REV. 1459, 1466 (1994)).
131.
Id. at 679.
132.
Id.
133.
Id. at 680. This type of thinking was echoed in a more recent article addressing in part why medical
savings accounts in which consumers of healthcare, namely the public, would be more frugal because they would
bargain with their physicians for services. The article compared this notion in the context of the doctor-patient
relationship like relying “in the sheep to negotiate with the wolves.” Atul Gawande, The Cost Conundrum, THE
NEW YORKER, June 1, 2009, at 44.
134.
In re Novartis, 593 F. Supp. 2d at 651.
135.
Id. (citing 29 C.F.R. § 541.503(a)) (“Promotional work that is actually performed incidental to and in
conjunction with an employee’s own outside sales or solicitations is exempt work. On the other hand, promotional
work that is incidental to sales made, or to be made, by someone else is not exempt outside sale work.”).
136.
Id. at 651-52 (citing Final Rule, supra note 19, at 22162).
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salespersons, namely to set the schedule for their work day, to have rare direct supervision, and to work away from the office. 137 For all of these reasons, the Novartis court concluded that the company’s sales representatives were exempt as outside salespersons under the FLSA.138
The inquiry did not end there, however. The court went on to conclude that
even in the absence of the outside sales exemption, the plaintiffs were also exempt
as administrative employees. 139 Initially, if the “administrative/production dichotomy” is applied, the plaintiffs were clearly not production employees because they
were not involved in the production of the defendant’s drugs. 140 Further, because
the sales representatives were responsible for disseminating Novartis’ information
into the marketplace, meaning to the prescribing physicians, their work went to the
heart of the company’s success, and they are involved in the general business operations sufficient to satisfy the first part of the test for the administrative employee
exemption. 141
The court then concluded that the sales representatives also exercised enough
independent judgment and discretion to satisfy the second prong of the test. Specifically, sales representatives were expected to “use initiative” to increase the
number of prescriptions written, typically by developing a rapport with the medical
staff with whom they had met, presenting information within certain parameters in
the most effective way in light of variables including time constraints, patient base,
and prescription history. 142 The sales representatives also set their schedules and
used their entertainment budgets to host events and thereby increase sales. 143 As a
result, the court determined that summary judgment was appropriate on this basis.
Similar reasoning was applied by the Pennsylvania district court in Baum v. Astrazeneca LP to grant the employer summary judgment in that case as well.144
On the other side of the spectrum are two cases from the federal district court
for the District of Connecticut.145 In Ruggeri v. Boehringer Ingelheim Pharma________________________
137.
Id. at 652. There is no doubt that the plaintiffs meet the minimum salary requirement to qualify for the
exemption. Id.
138.
Id. Interestingly, the Court then turned to the analogous California state overtime claims, and recognized that while the Barnick, Menes, and D’Este decisions may have been erroneous to some degree when considered in light of the California Supreme Court’s decision in Ramirez, 978 P.2d at 5-9, which held that it is inappropriate to rely on the FLSA and interpreting guidance concerning the outside sales exemption when analyzing
California state law on the issue because the language used for each exemption is not parallel, Ramirez was distinguishable from the case before the court because there the plaintiff was a deliveryman who also made sales and the
inquiry concerned the primary function of his job. Here the issue is whether the plaintiffs were making sales at all.
139.
In re Novartis, 593 F. Supp. 2d at 652.
140.
Id. at 655 (citing Reich v. John Alden Life Ins. Co., 126 F.3d 1 (1st Cir. 1997) (holding that insurance
company’s marketing representatives, who were the primary contacts with the agents that sold the policies, were
exempt because they were not involved in production work—they did not create the insurance policies being
written—rather they were involved in promoting them)).
141.
Id.
142.
Id. at 657.
143.
Id. Based on this same reason, the court also concluded that the plaintiffs were exempt as administrative employees under California law. Id. at 658. In Novartis, the court also engaged in a brief analysis of the
highly compensated employee exemption. Id. This exemption however is dependent to a certain degree on the
factors relating to the administrative employee exemption and therefore, is not reviewed here.
144.
Baum, 605 F. Supp. 2d 669.
145.
Kuzinski v. Schering Corp., 604 F. Supp. 2d 385 (D. Conn. 2009) (motion for interlocutory appeal
granted Apr. 17, 2009); Ruggeri v. Boehringer Ingelheim Pharm., Inc. (Ruggeri I), 585 F. Supp. 2d 254 (D. Conn.
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ceuticals, Inc., as in Novartis, the issue on summary judgment was whether pharmaceutical sales representatives were entitled to overtime pay under the FLSA, or
whether the representatives were exempt from the Act’s coverage, either because
the plaintiffs qualified as outside salespersons (both sides moved for summary
judgment on this issue) or administrative employees (only defendant moved for
summary judgment on this issue).146 And like in Novartis, the Ruggeri court determined that the initial inquiry concerning the outside sales exemption is whether
the employees were actually engaged in “sales.” 147 Yet the Connecticut district
court reached the opposite conclusion, reasoning that because the pharmaceutical
sales representatives did not actually make sales or obtain contracts for orders
when they visited physicians, they did not qualify as outside salespersons for FLSA
purposes.148 Specifically, the sales representatives did not and could not obtain
contracts or orders; they lacked the authority to negotiate the terms and conditions
of their employer’s sales; they were not permitted to negotiate or enter contracts
with healthcare professionals; and they did not take orders for products from the
pharmacies to which the products were sold. 149 Further, physicians did not place
orders for the products the sales representatives promoted.150 At most, the doctors
created a demand for the product by writing a prescription. 151 As a result, given
that the exemptions are to be narrowly construed as a matter of law, the sales representatives could not be said to make sales within the meaning of the statute. 152
In reaching this conclusion, the court declined to rely on the California cases
for three reasons.153 Initially, those cases were based on California state law, not
the FLSA, and the fact that the federal courts in California applied an FLSA analysis as persuasive authority does not mean that interpretations of California law are
persuasive authority for interpretation of the FLSA. 154 Second, the California Supreme Court has concluded that it is inappropriate to rely on federal regulations or
interpretations of the FLSA when applying the state’s outside sales exemption because the language of the two exemptions do not track each other, indicating an
intent that they are to be interpreted differently. 155 Accordingly, the California
decisions interpreting the state’s outside sales exemption based on the FLSA were
incorrectly reasoned, even if they might otherwise constitute persuasive authority.156
2008); Ruggeri v. Boehringer Ingelheim Pharm., Inc. (Ruggeri II), 585 F. Supp. 2d 308 (D. Conn. 2008) (motion
for reconsideration denied May 26, 2009).
146.
Ruggeri I, 585 F. Supp. 2d at 266-77.
147.
Id. at 266.
148.
Ruggeri I, 585 F. Supp. 2d at 267.
149.
Id.
150.
Id.
151.
Id. at 268.
152.
Id. at 267.
153.
Id. at 269.
154.
Id.
155.
Id. (citing Ramirez, 978 P.2d 2 (Cal. 1999)). See Sav-On Drug Stores, Inc. v. Superior Court, 96 P.3d
194, 206 (Cal. 2004) (Ramirez “reversed the Court of Appeal’s ruling that the plaintiff was exempt under an IWC
wage order defining ‘outside salesperson,’ largely because the court had inappropriately relied on certain federal
regulations, which varied from California law, in making that determination.”).
156.
Ruggeri I, 585 F. Supp. 2d at 269-70.
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Finally, the analysis in the California decisions was faulty because the courts
never conducted an initial inquiry as to the appropriate threshold question, namely,
whether the plaintiffs in those cases were actually engaged in sales. 157 Instead, the
courts incorrectly focused on an indicia-of-sales analysis, such as whether the jobs
at issue were advertised as “sales” positions, whether the employees referred to
themselves as sales people, whether they received commissions, whether they received sales training, and whether they operated independently. 158 For these reasons, those cases should not be followed.159
Similarly, the sales representatives did not qualify as administrative employees
as a matter of law. While no one disputes that the job required non-manual work
and met the minimum compensation thresholds, it could not be said on the factual
record presented whether the primary duties of the job related to the company’s
general business operations, or that while the job required the exercise of some
discretion, whether or not that discretion was exercised with respect to “matters of
significance.”160
Without a full factual record about Boehringer’s operations, it is
impossible to say whether the matters over which Plaintiffs had
discretion were matters of significance to Boehringer. The record
does not reveal, for example, whether demand for Boehringer’s
products was ever affected-or whether Boehringer’s revenues ever
fell-when PSRs other than Plaintiffs chose to formulate presentation ideas different from those [Plaintiff] Ms. Ruggeri formulated;
or used metrics different from those she used to determine which
physicians to entertain over a meal; or took a different route
through their geographical areas than did [Plaintiff] Mr. Jaramillo;
or stopped into retail pharmacies more or less frequently than he
did; or read physicians’ demeanors differently than [Plaintiff] Mr.
Naik in choosing when to be pushy, or even read physicians’ demeanors at all. Moreover, the record does not reveal whether Boehringer was even concerned about the effects of PSRs exercising
their discretion in different ways. As Plaintiffs point out . . .
[t]here is also no evidence of how significant Defendant considers
the matters it left to its PSRs’ discretion. The fact that Boehringer
so tightly controlled the message Plaintiffs presented to physicians

________________________

157.
Id.
158.
Id. at 266, 270-71 (noting that one of the California cases, D’Este, is “difficult to parse” and that the
plaintiff in that case would obtain a commitment from physicians to prescribe Bayer products and did sign a contract with a hospital to use Bayer products, unlike in the other sales representative cases, and which may have
supported the conclusion that the representative in that case was engaged in actual sales, unlike here). See also
Ruggeri II, 585 F. Supp. 2d at 315-16 (addressing D’Este).
159.
Id.
160.
Id. at 272-75.
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could be found to mean that Defendant left to its PSRs’ discretion
matters it considered insignificant.161
Accordingly, application of the administrative exemption on summary judgment was inappropriate. 162
In reaching this conclusion, the court distinguished the 1945 Department of
Labor Opinion Letter concluding that “medical detailists” were exempt administrative employees because those employees had different responsibilities, including
that they were consulted with respect to nutritional problems encountered by hospitals and determined whether the use of a subject’s product was related to the occurrence of an epidemic—responsibilities that the pharmaceutical sales representatives in this case did not have. 163
The court subsequently denied the defendant’s motion for an interlocutory appeal with respect to its decision granting the plaintiffs’ motion for summary judgment concluding that they were not exempt as outside salespersons under FLSA,
rejecting the argument that there was a substantial ground for difference of opinion
on this issue. 164 At the time of this decision, the Novartis decision on summary
judgment had not yet been handed down.
More recently, in Kuzinski v. Schering Corporation, the federal district court in
Connecticut had an opportunity to revisit the issue, this time after the Novartis decision had been rendered. 165 Similar to the other cases, the plaintiffs were sales
representatives whose job was to “introduce[] and make known its prescription
drugs to physicians, pharmacists, hospitals, managed care organizations, and buying groups.”166 Company revenue was dependent upon physician prescriptions. 167
To increase market share, the employer also relied upon its sales representatives
who met with medical professionals in assigned territories and encouraged the prescription of company products.168 Nevertheless, the sales representatives did not
enter into contracts on the employer’s behalf for company products, obtain orders,
or get binding commitments.169
As in other cases, the work required the representatives to be out of the company offices, doing field work, meeting with doctors, entertaining at lunches and dinners, and attending training sessions and conferences.170 The company chose
which physicians the sales representative would “target.” 171 Supervision of field
work occurred when a district manager would sometimes “ridealong” with the
________________________

161.
162.
163.
164.
165.
Novartis).
166.
167.
168.
169.
170.
171.

Ruggeri I, 585 F. Supp. 2d at 275-76.
Id. at 276-77.
Id. at 276.
Ruggeri II, 585 F. Supp. 2d at 311.
Kuzinski, 604 F. Supp. 2d at 385 (motion for interlocutory appeal granted April 17, 2009) (addressing
Id. at 386-87.
Id. at 388.
Id.
Id. at 391.
Id. at 388.
Id. at 389.
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sales representative. 172 Sales representatives were paid a base salary plus incentive
payments, which in turn were based roughly on the number of company products
prescribed in the representatives’ respective geographic territories. 173 The company characterized the work as “sales,” considered the plaintiffs’ conduct as “selling,” and sought people with “sales skills” to fill the sales representative positions. 174
Analyzing these facts, which are similar to those in Ruggeri, the court came to
the same conclusion that the plaintiff-sales representatives were not exempt from
the FLSA as outside salespersons. 175 In so doing, the court criticized the Novartis
court’s outside sales analysis on several grounds. 176 Initially, in order to qualify as
an outside salesperson, the employee has to make “sales.”177 Applying the FLSA’s
definition of that term, the sales representatives clearly did not engage in any sale,
exchange, contract to sell, consignment for sale or other disposition, shipment for
sale, or transfer of title to tangible property as required under the statute and regulations. 178 In fact, the sales representatives and physicians lacked the capacity to
consummate sales, as the sales representatives are barred by law and by their employers from entering into contracts or binding commitments with doctors for prescriptions. 179 Accordingly, any argument that the plaintiffs were exempt is based on
nothing more than an artificial attempt to “back-fit” the FLSA onto industry practices.180 At most, the sales representatives worked to increase overall demand for a
product by “laying the groundwork” for another employee to obtain a commitment
for a purchase which, by definition, is non-exempt work.181
The court also distinguished Medtronic, Inc. v. Gibbons and relied upon in the
Novartis decision for its description of the work that sales representatives of cardiac pacemaker manufacturers did in promoting the company’s products. 182 While
the Novartis court relied upon Medtronic’s discussion that the company sold its
products to hospitals based on physicians’ recommendations, the decision in that
case was unrelated to the FLSA’s outside sales exemption and did not analyze the
term “sales” as applied under the Act or the rule requiring narrow interpretation of
________________________

172.
Id. at 388.
173.
Kuzinski, 604 F. Supp. 2d at 389-90.
174.
Id. at 390.
175.
Id. at 402-03.
176.
Id. at 397-98. However, the court in Kuzinski did not engage in an administrative employee exemption.
177.
Id. at 397 (citing Clements v. Serco, 530 F.3d 1224, 1227 (10th Cir. 2008) (civilian military recruiters
for the army are not outside salesmen even though they engaged in sales training and “sold” the idea of joining the
army to potential recruits)).
178.
Id. at 398; 29 U.S.C. § 203(k); 29 C.F.R. § 541.501(b).
179.
Id. at 398.
180.
Id. at 399. See Ruggeri I, 585 F. Supp. 2d at 272.
181.
Kuzinski, 604 F. Supp. 2d at 399. The court also distinguished Gregory v. First Title of Amer., Inc.,
555 F.3d 1300, 1309 (11th Cir. 2009) on the ground that there the marketing executive did make sales, because
once an order for title insurance services was obtained by the plaintiff, the sale was complete. In Kuzinski, the
marketing executive did all of the work necessary to reach an agreement with a customer. Pharmaceutical sales
representatives on the other hand do not even communicate with the entities that do the actual purchasing of their
products. Kuzinski, 604 F. Supp. 2d at 399-400.
182.
Kuzinski, 604 F. Supp. 2d at 399.
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the statutory exemptions.183 Accordingly, Medtronic is inapposite, and the Novartis decision was wrongly decided. 184 That being said, in the wake of the Novartis
decision, this time the district court granted the defendant’s motion for an interlocutory appeal. 185
Still, other courts take a position somewhere in between Novartis, Baum and
the California cases on the one hand and Ruggeri and Kuzinski on the other.
Amendola v. Bristol-Myers Squibb, another case in the federal district court for the
Southern District of New York, involved a motion for discovery of the names and
addresses of potential class members, authorization for notice of a collective action
to be sent, and equitable tolling of any claims to be filed. 186 As with other pharmaceutical companies, the sales representatives promoted company products to physicians, hospitals, clinics and medical institutions, worked outside the company offices and were paid a salary plus incentive compensation. 187 Their primary responsibility was to be in the field visiting medical providers to influence prescription
practices.188 Each representative was given a list of medical providers to call,
guidelines for how many calls should be made on an average day, and a core message to deliver.189 The sales representatives set their own daily and weekly schedules and could add and subtract from their list of assigned providers subject to
supervisor approval.190
Like the other cases, the physicians visited did not buy drugs. 191 Rather, they
wrote the prescriptions for patients to present to pharmacies to purchase the prescribed medication.192 The sales representatives also did not sell drugs to providers
or take orders for drugs.193 The representatives in this case did, however, ask for
non-binding commitments to prescribe the medications they were promoting.194
Again, the court’s inquiry began with whether the plaintiffs were actually engaged in “sales” work.195 In reviewing the sales representatives’ responsibilities,
the court readily determined that influencing physicians to prescribe drugs and
obtain non-binding commitments do not constitute a sale, exchange, contract to
sell, consignment for sale or a shipment for sale “as these terms are customarily
understood” under the FLSA.196 Indeed, the Amendola court went so far as to cha________________________

183.
Id. at 400-01. Palmieri v. Nynex Long Distance Co., No. Civ. 04-138-PS, 2005 WL 767170 (D. Me.
Mar. 28, 2005), aff’d, 437 F.3d 111 (1st Cir. 2006) is also inapplicable because in that case, there was no dispute
that the plaintiff made some sales. As a result, an indicia-of-sales review was appropriate. Here, because the sales
representatives make no sales, the subsequent indicia-of-sales analysis does not apply.
184.
See Kuzinski, 604 F. Supp. 2d at 397, 401.
185.
Kuzinski v. Schering Corp., 614 F. Supp. 2d 247 (D. Conn. 2009) (court order denying motion for
certification as collective action without prejudice and granting motion for interlocutory appeal).
186.
Amendola v. Britsol-Myers Squibb Co., 558 F. Supp. 2d 459, 462 (S.D.N.Y. 2008).
187.
Id. at 463.
188.
Id.
189.
Id. at 464.
190.
Id.
191.
Id.
192.
Amendola, 558 F. Supp. 2d at 464.
193.
Id.
194.
Id.
195.
Id. at 470.
196.
Amendola, 558 F. Supp. 2d at 470-71. See 29 U.S.C. § 203(k).
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racterize this conclusion as “unsurprising” given that the medical providers do not
purchase the drugs from the sales representatives and, in fact, that federal law prohibits the sales representatives from selling pharmaceutical products.197
In reaching this conclusion, the court, like in Ruggeri, rejected the argument
that the plaintiffs were exempt because they received specialized training, were
given sales titles, their positions as originally advertised were in sales, and they
lacked direct supervision. 198 This is because these factors become relevant only
where the employee has “mixed duties” involving sales and non-sales work. 199
Here, the employees did not do any sales work at all. 200
Similarly, the court declined to follow the California cases because those cases,
which interpreted state law, failed to acknowledge that the FLSA exemptions are to
be narrowly construed against the employers and relied on the various factors applicable in a mixed duty analysis without “grappling” with whether the plaintiffs
were actually engaged in sales.201 For these reasons, they were erroneously decided.
The Amendola court then reached the same conclusion as the other New York
federal district court did in Novartis with respect to the administrative employee
determination.202 Bristol-Myers’s sales representatives, who clearly do non-manual
work and earn above the mandatory minimum, represent the company in meetings
with medical providers to promote company drugs. 203 Accordingly, reasoned the
court, company success depends in part on the sales representatives’ ability to educate physicians about Bristol-Myers’s drugs, and as such, the work is “directly related to . . . management or business operations.” 204 Considering the administrative/production distinction, the court held that because the company’s products are
the drugs it designs, patents, and manufactures, and the sales representatives do not
produce these products, they fall on the administrative side of the line. 205
Next, the court concluded that the plaintiffs’ work involved exercise of the type
of discretion and independent judgment concerning matters of significance sufficient to render the work exempt.206 Specifically, each representative tailored the
content of his or her presentation to each medical provider based on a variety of
factors and independently decided what message would be most effective. 207 Further, each one strategically managed a call list, exercising judgment in deciding
how often to visit a doctor or whether to add new providers to that list.208 In this
case, the representatives also managed samples, deciding how effectively each provider would use the samples and determining how best to manage promotional
________________________
197.
198.
199.
200.
201.
202.
203.
204.
205.
206.
207.
208.

Id.
Id.
Id. at 472.
Id. at 471.
Id. at 472.
Id. at 472-77.
Amendola, 558 F. Supp. 2d at 476-77.
Id. at 477.
Id.
Id.
Id.
Id.
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budgets, organizing group lectures or individual meals for providers. 209 These decisions were made free from supervision and drove the company’s business. 210
Based on all of these facts, the court concluded that there was sufficient likelihood
that the sales representatives were exempt administrative employees to deny their
motion for authorization to send out notice of the lawsuit to other employees with
potential claims. 211
The federal district court in New Jersey came to a conclusion similar to that in
Amendola. Relying on the rationale applied in Ruggeri, the court in Smith v. Johnson & Johnson held that the pharmaceutical sales representatives in that case were
not exempt from FLSA overtime requirements as outside salespersons. 212 Where
the employees had no capacity to make actual sales, they did not qualify for the
exemption. 213 While it is true that physicians create a “chokepoint” in the sales of
pharmaceuticals, this reality does not change the analysis. 214 Where the plaintiffs’
conduct could not wind up in anything more than a non-binding declaration of intent to prescribe a drug, this is not enough to constitute “sales” under the FLSA and
invoke the exemption. 215
Nevertheless, following the Amendola decision, the New Jersey federal district
court concluded that the sales representatives were exempt from the FLSA’s overtime requirements as administrative employees.216 Although the plaintiffs’ work
does not dictate corporate marketing policy, it does drive market demand and,
therefore, substantially affects the operation of a particular segment of the business
as required under the Department of Labor’s interpretation of the exemption. 217
Similarly, under the administrative/production dichotomy, the sales representatives
were not production workers because the employer’s business is not about educating physicians about their products, rather it is about manufacturing and distributing those products.218 In terms of exercising discretion and independent judgment,
while the court recognized that the plaintiffs in Amendola had more discretion than
Smith in this case, the fact that the plaintiff was able to request permission to visit
new physicians and update her marketing plan to be more effective in her territory,
even though she needed supervisory approval, was sufficient to qualify her as exempt under the FLSA. 219 This conclusion was further supported by Smith’s work
driving the market for the drugs she worked with and her involvement with her

________________________

209.
210.
211.
212.
30, 2008).
213.
214.
215.
216.
217.
218.
219.

Id.
Amendola, 558 F. Supp. 2d at 477.
Id.
Smith v. Johnson & Johnson, Civil Action No. 06-4787 (JLL), 2008 WL 5427802, at *6 (D.N.J. Dec.
Id. at *7.
See id.
Id. at *7.
Id. at *10.
Id. (citing Final Rule, supra note 19, at 22138).
Smith, 2008 WL 5427802, at *11.
Id.
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manager planning long-term and short-term business objectives.220 Accordingly,
summary judgment was granted in favor of the defendant. 221
ANOTHER INTERPRETATION
There is another statutory interpretation based on a simple analysis which leads
to a more straightforward result than any of the decisions above. The FLSA defines the term “sale” as “any sale, exchange, contract to sell, consignment for sale,
shipment for sale, or other disposition.”222 The phrase “other disposition,” which is
not defined in the statute or the regulations, has received little attention from the
courts. Accordingly, as the Supreme Court has repeatedly recognized, under standard rules of statutory construction, the term should be given its ordinary meaning.223
The American Heritage College Dictionary defines “disposition” in relevant
part as an “[a]rrangement, positioning, or distribution;” a “final settlement;” an “act
of disposing of; a bestowal or transfer to another;” and “[t]he power or liberty to
control, direct, or dispose” and “[m]anagement control.” 224 Webster’s New International Dictionary defines the term similarly as the “[a]ct or power of disposing,
or state of being disposed;” and “[t]he administering of anything; management.” 225
The same sources define the term “dispose” as “[t]o place or set in a particular order; arrange;” “[t]o put [(business affairs, for example)] into correct, definitive, or
conclusive form;” “[t]o settle or decide a matter;” “[t]o distribute and put in place;
to arrange; to set in order;” “[t]o assign to a certain place or condition; appoint;”
and “[t]o regulate; adjust; settle; determine.” 226
Applying these definitions, it is logical to conclude that the term “other disposition,” as it is used to define a “sale” under the Act, includes a physician’s decision to write a prescription for a particular medication. As the district court in
Baum recognized, the purchase of pharmaceuticals does not operate in a typical
free market. As part of the “professional paradigm,” the specialized knowledge
necessary to make decisions concerning the purchase of drugs is beyond the ability
of the typical layperson. As a result, the decision-making process is essentially
assigned by the end purchaser—the patient—to a middleman—the physician. In
fact, this assignment of responsibility is required as the medications at issue cannot
be purchased in the absence of a prescription. The doctor then takes this assigned
responsibility and executes it, although not by physically making the purchase, a
ministerial act. Rather, the physician writes a prescription, the only legal method
by which the drugs can be purchased. While it is true that the act of writing the
prescription may not constitute a “sale” in the traditional sense, after all a patient
________________________
220.
Id. at *12 (citing 29 C.F.R. § 541.202(b)).
221.
Id.
222.
29 U.S.C. § 203(k) (emphasis added).
223.
See, e.g., Gross v. Financial Servs., Inc., 129 S. Ct. 2343, 2350 (2009) (using dictionaries to analyze
statutory terms); Engine Mfrs. Ass’n v. S. Coast Air Quality Mgmt. Dist., 541 U.S. 246, 252-53 (2004).
224.
AMERICAN HERITAGE COLLEGE DICTIONARY 401 (3d ed. 1997).
225.
WEBSTER’S NEW INTERNATIONAL D ICTIONARY 752 (2d ed. 1950).
226.
See supra note 224, at 250; supra note 225, at 117.

Published by Digital Commons @ Barry Law, 2009

25

Barry Law Review, Vol. 13, Iss. 1 [2009], Art. 1

Barry Law Review

26

Vol. 13

may never go to the pharmacy to pick up or pay for the medication, under a dictionary definition it does constitute a “management” of the process and exercise of the
“[t]he power or liberty to control” the decision about whether the purchase of a
prescribed medication is appropriate in a particular instance and which medication
is best suited for that situation. Accordingly, it is appropriate for the courts to conclude that the pharmaceutical sales representatives’ core function—to influence
physician prescription practices—constitutes an “other disposition” as that term is
used to define a “sale” under the FLSA. As a result, the pharmaceuticals sales representatives’ “primary duty” is clearly to engage in “sales,” and they should be
treated as exempt outside salespersons not covered by the Act’s overtime requirements.
Whether the sales representatives’ work qualifies as exempt administrative
work is a more nuanced question because it cannot be answered by looking at the
job’s central function—namely to influence medical prescription practices, and
some of the other job responsibilities vary by employer.227 Nevertheless, a review
of some of the aspects of the job common across the industry reveals that this exemption likely does not apply here, or at least as the court in Ruggeri concluded,
not as a matter of law. The Department of Labor has expressly recognized that
work “promoting sales” constitutes the type of “servicing,” as opposed to production work that directly relates to the general business operations of a company,
such that sales representative work might qualify as the type of administrative responsibilities exempt under the FLSA.228
Nevertheless, the work appears to lack the type of exercise of discretion and
independent judgment that exempt administrative work requires. While it is true
that the sales representatives typically operate without much direct supervision and
set their schedules on a daily basis, this alone is not enough to satisfy the test. As
set forth above, the applicable regulations issued by the Department of Labor set
forth a non-exclusive list which demonstrates the type of discretion required to
invoke the exemption. 229 A review of this list indicates that the sales representatives’ work is non-exempt. Generally speaking, pharmaceutical sales representatives do not have the authority to formulate, affect, interpret, or implement management policies or operating practices. They do not carry out major assignments
in conducting the operations of the business. While as a group, their work affects
business operations, each representative is typically assigned only a small number
of products in a narrow territory, limiting the impact of any one or small group of
representatives. The sales representatives do not have the authority to commit the
employer to matters having a significant financial impact. They are not authorized
to waive or deviate from established policies or procedures without approval. They
do not have the authority to negotiate or bind the company on significant matters,
and they are not involved in planning long-term or short-term business objectives,
at least not beyond their own sales objectives, satisfaction of which typically leads
________________________

227.
228.
229.

See, e.g., Smith, 2008 WL 5427802, at *11 (noting responsibilities vary by company).
Final Rule, supra note 19, at 21138.
29 C.F.R. § 541.202(b).
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to increased compensation. They also are not authorized to resolve matters of significance on behalf of management, and they do not represent the company in handling complaints or dispute resolution. Rather, the sales representatives are more
involved in carrying out the day-to-day operations of the business. All of these
factors weigh against invoking the administrative exemption.
While it is true that the sales representatives do decide how to best formulate
their presentations to physicians to increase sales, this responsibility is unconvincing as a basis upon which to invoke the exemption. 230 As the Ruggeri court recognized, there is little evidence that the sales representatives’ exercise of discretion
was with regard to any matter that the employers considered significant.231 Indeed,
if this type of exercise of discretion were enough, it is hard to imagine an outside
sales representative who spends the majority of his or her time in the field that
would not qualify as an administrative employee.
In reaching this conclusion, it should be noted that the medical detailists addressed in the Department of Labor’s 1945 Opinion Letter are different than the
sales representatives involved in current litigation. Unlike the medical detailists,
there is no indication in any of the recent cases that the sales representatives are
consulted with respect to individual nutrition problems or whether a product is related to the outbreak of something like an epidemic. There is also no discussion of
the sales representatives at issue training other sales personnel. 232 Accordingly, the
Opinion Letter is of little value to the analysis here. In short, while there may be
exceptions, as a general matter, pharmaceutical sales representatives likely do not
qualify as administrative employees under the FLSA.
CONCLUSION
Whether sales representatives in the pharmaceutical industry are entitled to
overtime under the Fair Labor Standards Act is unclear from the decisions of the
federal district courts across the country. The issue is complicated because, although the function of these employees is to increase sales, they do not address
their efforts to the actual purchaser of the products they represent. Yet, a careful
review of the Act reveals that although sales representatives generally lack sufficient discretion to qualify them as administrative employees, their work is sufficiently sales-based to invoke the FLSA’s statutory exemption for outside salesperson. Accordingly, as these cases wind their way through the appellate process, the
courts should conclude that pharmaceutical sales representatives are not entitled to
overtime pay.

________________________

230.
See, e.g., Amendola, 558 F. Supp. 2d at 472-77 (applying the administrative employee exemption).
231.
See supra notes 161-162 and accompanying text.
232.
See Applicability of Exemption for Administrative Employees to Medical Detailists, supra notes 71-74
and accompanying text.

Published by Digital Commons @ Barry Law, 2009

27

